ctrl K

Barinthus Biotherapeutics (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

1.13

0.01 (0.89%)

At close: May 01, 2025, 3:59 PM

1.09

-3.50%

Pre-market: May 02, 2025, 08:10 AM EDT

Barinthus Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	14.97M	802K	44.7M	268K	4.82M	6.87M
Cost of Revenue	5.8M	n/a	n/a	n/a	n/a	-0.55
Gross Profit	9.17M	802K	44.7M	268K	4.82M	6.87M
Operating Income	-67.97M	-83.91M	-4.04M	-45.22M	-20.05M	-25.77M
Interest Income	2.68M	2.88M	3.1M	2K	267.06	40.37K
Pretax Income	-61.23M	-76.52M	850K	-51.14M	-17.84M	-22.79M
Net Income	-61.07M	-73.35M	5.34M	-50.87M	-17.71M	-20.82M
Selling & General & Admin	29.67M	39.84M	6.39M	25.12M	10.48M	2.33M
Research & Development	38.25M	41.41M	41.11M	16.37M	11.11M	29.97M
Other Expenses	15.02M	3.46M	567K	332K	42K	0.00
Operating Expenses	82.94M	84.72M	47.5M	41.49M	21.59M	32.3M
Interest Expense	53K	28K	19K	2.67M	3.6M	133.3K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	82.94M	84.72M	47.5M	41.49M	21.59M	32.64M
Income Tax Expense	-153K	-3.17M	-4.47M	-28K	95K	-2.02M
Shares Outstanding (Basic)	39.35M	38.39M	37.25M	37.19M	47.65K	n/a
Shares Outstanding (Diluted)	39.35M	38.39M	38.17M	37.19M	47.65K	n/a
EPS (Basic)	-1.55	-1.91	0.14	-1.37	-371.62	n/a
EPS (Diluted)	-1.55	-1.91	0.14	-1.37	-371.62	n/a
EBITDA	-59.38M	-71.06M	6.4M	-47.86M	-14.14M	-22.31M
EBIT	-61.17M	-76.49M	869K	-48.47M	-14.24M	-22.66M
Depreciation & Amortization	1.79M	5.45M	5.54M	601.93K	210.02K	346.86K